Form 4 for CTNM Contineum Therapeutics, Inc.
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-19 · accession 0001437749-26-004912 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-20 | 2026-02-19 | CTNM | Lorrain Daniel S. | CSO | S - Sale+OE | $16.00 | -100 | 156.1K | -0.1% | -$1,600 |
| D | 2026-02-20 | 2026-02-19 | CTNM | Lorrain Daniel S. | CSO | M - OptEx | $1.01 | +100 | 156.2K | +0.1% | +$101 |
| D | 2026-02-20 | 2026-02-19 | CTNM | Lorrain Daniel S. | CSO | M - OptEx | $0.00 | -100 | 75.4K | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-19 | S | D | 100 | $16.00 | 156,052 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-02-19 | M | A | 100 | $1.01 | 156,152 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-02-19 | M | D | 100 | $0.00 | 75,430 | D | $1.01 · — to 2030-02-24 | 100 Class A Common Stock | (F2) The stock options are fully vested and exercisable. |